| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Avecho Biotechnology Limited (AU: AVE)
AVE Technical Analysis
1
| As on 27th Nov 2024 AVE STOCK Price closed @ 0.00 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AVESTOCK Price
| Open | 0.00 | Change | Price | % |
| High | 0.00 | 1 Day | N/A | N/A |
| Low | 0.00 | 1 Week | 0.00 | 0.00 |
| Close | 0.00 | 1 Month | 0.00 | 0.00 |
| Volume | 30424133 | 1 Year | 0.00 | 0.00 |
| 52 Week High 0.00 | 52 Week Low 0.00 | ||||
AU Australia Most Active Stocks
| SYA | 0.03 | 0.00% |
| OVT | 0.03 | % |
| PLS | 2.43 | -1.62% |
| RDN | 0.02 | 0.00% |
| ERA | 0.00 | % |
| MMI | 0.06 | % |
| AVE | 0.00 | % |
| RSG | 0.40 | 2.56% |
| MRQ | 0.00 | % |
| FGL | 0.04 | 0.00% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| AVE Daily Charts |
AVE Intraday Charts |
Whats New @ Bazaartrend |
AVE Free Analysis |
|
|
AVE Important Levels Intraday
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
AVE Forecast November 2024
| 4th UP Forecast | 0 |
| 3rd UP Forecast | 0 |
| 2nd UP Forecast | 0 |
| 1st UP Forecast | 0 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | 0 |
| 4th DOWN Forecast | 0 |
AVE Weekly Forecast
| 4th UP Forecast | 0.00 |
| 3rd UP Forecast | 0.00 |
| 2nd UP Forecast | 0.00 |
| 1st UP Forecast | 0.00 |
| 1st DOWN Forecast | 0.00 |
| 2nd DOWN Forecast | 0.00 |
| 3rd DOWN Forecast | 0.00 |
| 4th DOWN Forecast | 0.00 |
AVE Forecast2024
| 4th UP Forecast | 0 |
| 3rd UP Forecast | 0 |
| 2nd UP Forecast | 0 |
| 1st UP Forecast | 0 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | 0 |
| 4th DOWN Forecast | 0 |
Avecho Biotechnology Limited ( AU Australia Symbol : AVE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AVE Business Profile
Avecho Biotechnology Limited, a biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, animal health, and nutrition industries in Australia and internationally. The company operates through Production, Human Health, and Other segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 is based in Clayton, Australia. Address: 2A Westall Road, Melbourne, VIC, Australia, 3168
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service